Agomelatine: an agent against anhedonia and abulia?

Disruption of circadian rhythms due to chronic constant light leads to depressive and anxiety-like behaviors in the rat

(2013) Araceli Tapia-Osorio et al.   BEHAVIOURAL BRAIN RESEARCH

Dim light at night increases depressive-like responses in male C3H/HeNHsd mice

(2013) Laura K. Fonken et al.   BEHAVIOURAL BRAIN RESEARCH

Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials

(2013) Markus Koesters et al.   BRITISH JOURNAL OF PSYCHIATRY

A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline

(2013) Koen Demyttenaere et al.   CNS SPECTRUMS

The efficacy of agomelatine in previously-treated depressed patients

(2013) Siegfried Kasper et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Successful use of agomelatine and venlafaxine combination in major depression

(2013) Ajit Bhalchandra Dahale et al.   GENERAL HOSPITAL PSYCHIATRY

Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression

(2013) Dan J Stein et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice

(2013) Domenico De Berardis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial

(2013) Emmanuelle Corruble et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder

(2013) Reinhard Heun et al.   JOURNAL OF CLINICAL PSYCHIATRY

Biological rhythms and melatonin in mood disorders and their treatments

(2013) Laurence Lanfumey et al.   PHARMACOLOGY & THERAPEUTICS

Serotonin and beyond: therapeutics for major depression

(2013) P. Blier et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Agomelatine reversal of escitalopram-induced apathy: A case report

(2013) Domenico De Berardis et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Agomelatine-induced hepatotoxicity

(2013) Matej Štuhec   WIENER KLINISCHE WOCHENSCHRIFT

Agomelatine as monotherapy for major depression: an outpatient, open-label study

(2013) Jan Pecenak   Neuropsychiatric Disease and Treatment

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study

(2013) Michele Fornaro et al.   Neuropsychiatric Disease and Treatment

Anhedonia and major depression: The role of agomelatine

(2012) Massimo Di Giannantonio et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder

(2012) Giovanni Martinotti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Personalized medicine in major depressive disorder — Opportunities and pitfalls

(2012) Diane B. Miller et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Electrophysiological Effects of Repeated Administration of Agomelatine on the Dopamine, Norepinephrine and Serotonin Systems in the Rat Brain

(2012) Franck Chenu et al.   NEUROPSYCHOPHARMACOLOGY

Severe insomnia is associated with more severe presentation and greater functional deficits in depression

(2011) Erin M. O’Brien et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Sidney H. Kennedy et al.   CNS DRUGS

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Stephen M. Stahl et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder

(2010) John Zajecka et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Reconsidering anhedonia in depression: Lessons from translational neuroscience

(2010) Michael T. Treadway et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults

(2010) Robert Howland   Neuropsychiatric Disease and Treatment

Agomelatine

(2009) Sidney H. Kennedy   CNS DRUGS